You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 149 No. 2, February 1995 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Articles
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Theophylline Does Not Shorten Hospital Stay for Children Admitted for Asthma

Joshua P. Needleman, MD; Marie C. Kaifer, MD; Jeffery T. Nold, DO; Paul E. Shuster, MD; Mark M. Redding, MD; Jack Gladstein, MD

Arch Pediatr Adolesc Med. 1995;149(2):206-209.


Abstract



Objective
To determine if the use of intravenous theophylline, in the form of aminophylline, when added to systemic corticosteroids and aerosolized β2-agonists, enhances the improvement of children with acute asthma exacerbations.

Design
A double-blind, placebo-controlled, randomized, clinical trial.

Setting
The University of Maryland Medical Center, Baltimore, an urban primary- and tertiary-care pediatric medical center.

Patients
Forty-two children, aged 2 to 18 years, admitted to the hospital for acute exacerbations of asthma.

Methods
Patients were randomized to receive either intravenous theophylline to maintain a serum level greater than 55 µmol/L or a placebo infusion. All patients received methylprednisolone and nebulized albuterol. A clinical severity score was assessed twice daily.

Results
The mean length of stay for the treatment and control groups was 52.3±32.3 hours and 48.2±26.6 hours, respectively (t=0.45, P=.65). The rate of improvement of clinical scores was similar.

Conclusion
These data suggest that the addition of theophylline to albuterol and corticosteroids does not enhance improvement of children admitted to the hospital with asthma.

(Arch Pediatr Adolesc Med. 1995;149:206-209)



Author Affiliations



From the Departments of Pediatrics, University of Maryland School of Medicine, Baltimore.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

IV Theophylline Still Works in Severe Status Asthmaticus
Bratton
AAP Grand Rounds 2001;6:13-14.
FULL TEXT  

Efficacy of IV Theophylline in Children With Severe Status Asthmaticus
Ream et al.
Chest 2001;119:1480-1488.
ABSTRACT | FULL TEXT  

The Management of Acute Severe Asthma
Kelly
Journal of Pharmacy Practice 2001;14:91-107.
ABSTRACT  

Randomised controlled trial of aminophylline for severe acute asthma
Yung and South
Arch. Dis. Child. 1998;79:405-410.
ABSTRACT | FULL TEXT  

UPDATES ON PEDIATRIC ASTHMA
JWatch General 1995;1995:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.